Correlation Between Regeneron Pharmaceuticals and NYSE Composite

Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and NYSE Composite at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and NYSE Composite into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regeneron Pharmaceuticals and NYSE Composite, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and NYSE Composite and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of NYSE Composite. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and NYSE Composite.

Diversification Opportunities for Regeneron Pharmaceuticals and NYSE Composite

-0.27

Correlation Coefficient

Regeneron Pharmaceuticals  NYSE Composite

Very good diversification

The 3 months correlation between Regeneron and NYSE is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and NYSE Composite in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NYSE Composite and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with NYSE Composite. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NYSE Composite has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and NYSE Composite go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and NYSE Composite

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 10.86 times less return on investment than NYSE Composite. In addition to that, Regeneron Pharmaceuticals is 2.01 times more volatile than NYSE Composite. It trades about 0.0 of its total potential returns per unit of risk. NYSE Composite is currently generating about 0.06 per unit of volatility. If you would invest  1,553,974  in NYSE Composite on September 27, 2024 and sell it today you would earn a total of  380,174  from holding NYSE Composite or generate 24.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Regeneron Pharmaceuticals  vs.  NYSE Composite

Pair Trading with Regeneron Pharmaceuticals and NYSE Composite

The main advantage of trading using opposite Regeneron Pharmaceuticals and NYSE Composite positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, NYSE Composite can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NYSE Composite will offset losses from the drop in NYSE Composite's long position.

The idea behind Regeneron Pharmaceuticals and NYSE Composite pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.